# A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy

Study · id `cardio:ct-nct01258673` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01258673](<https://clinicaltrials.gov/study/NCT01258673>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01258673

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 263 participants.

## Technical summary

Registry record NCT01258673. Randomized; triple masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2011-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 263 participants (enrolled count; ClinicalTrials.gov record NCT01258673, source copy `cardio:ctgov-nct01258673-2012-01-05`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01258673, source copy `cardio:ctgov-nct01258673-2012-01-05`, retrieved 2026-10-26)
- Primary completion: 2011-12 (actual) (ClinicalTrials.gov record NCT01258673, source copy `cardio:ctgov-nct01258673-2012-01-05`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: South Korea (ClinicalTrials.gov record NCT01258673, source copy `cardio:ctgov-nct01258673-2012-01-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01258673-2012-01-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
- Condition: Essential Hypertension
- Intervention (Drug): Fimasartan/HCTZ combination
- Intervention (Drug): Fimasartan
- Lead sponsor: Boryung Pharmaceutical Co., Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: Seoul National University Hospital
- Collaborator class: OTHER
- Collaborator: The Catholic University of Korea
- Collaborator class: OTHER
- Collaborator: Korea University Guro Hospital
- Collaborator class: OTHER
- Collaborator: DongGuk University
- Collaborator class: OTHER
- Collaborator: Seoul National University Bundang Hospital
- Collaborator class: OTHER
- Collaborator: Samsung Medical Center
- Collaborator class: OTHER
- Collaborator: Asan Medical Center
- Collaborator class: OTHER
- Collaborator: Gangnam Severance Hospital
- Collaborator class: OTHER
- Collaborator: Severance Hospital
- Collaborator class: OTHER
- Collaborator: Ajou University
- Collaborator class: OTHER
- Collaborator: Chonbuk National University Hospital
- Collaborator class: OTHER
- Collaborator: Cheil General Hospital and Women's Healthcare Center
- Collaborator class: OTHER
- Collaborator: Chonnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Hanyang University Guri Hospital
- Collaborator class: OTHER
- Collaborator: Yonsei University
- Collaborator class: OTHER
- Collaborator: Ilsan-Paik Hospital
- Collaborator class: UNKNOWN
- Collaborator: SMG-SNU Boramae Medical Center
- Collaborator class: OTHER
- Collaborator: Kyung Hee University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy (`cardio:pubmed-26082615`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 14 registry organizations

## Provenance

Content hash: f321bf5d099019f827eea7c4bb358e939c5c5cd8b0fd229ebeafd58c756f8726
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
